<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">uzspbgmu</journal-id><journal-title-group><journal-title xml:lang="ru">Учёные записки Первого Санкт-Петербургского государственного медицинского университета имени академика И. П. Павлова</journal-title><trans-title-group xml:lang="en"><trans-title>The Scientific Notes of the Pavlov University</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-4181</issn><issn pub-type="epub">2541-8807</issn><publisher><publisher-name>Academician I.P. Pavlov First St. Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1607-4181-2022-29-2-32-40</article-id><article-id custom-type="elpub" pub-id-type="custom">uzspbgmu-873</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ РАБОТЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Оценка динамики биомаркеров аутофагии и апоптоза в остром периоде ишемического инсульта методом проточной цитометрии</article-title><trans-title-group xml:lang="en"><trans-title>Assessment of the dynamics of autophagy and apoptosis biomarkers in the acute period of ischemic stroke using flow cytometry</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7690-9064</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Луговая</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lugovaya</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Луговая Анна Владимировна, кандидат медицинских наук, ассистент кафедры клинической лабораторной диагностики с курсом молекулярной медицины, врач клинической лабораторной диагностики отделения лабораторной диагностики клиники</p><p>SPIN-код: 4350-2349, AuthorID: 370654</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Lugovaya Anna V., Cand. of Sci. (Med.), Assistant of the Department of Clinical Laboratory Diagnostics with a Course in Molecular Medicine, Doctor of Clinical Laboratory Diagnostics, Clinic of the Department of Laboratory Diagnostics</p><p>Saint Petersburg</p></bio><email xlink:type="simple">lugovaya2710spb@icloud.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5649-6090</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Эмануэль</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Emanuel</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Эмануэль Юлия Владимировна, кандидат медицинских наук, доцент кафедры неврологии и мануальной медицины Факультета последипломного образования, врач-невролог клиники </p><p>Санкт-Петербург</p><p> </p></bio><bio xml:lang="en"><p>Emanuel Yuliya V., Cand. of Sci. (Med.), Associate Professor of the Department of Neurology and Manual Medicine, Faculty of Postgraduate Education, Neurologist of the Clinic of the Neurological Department</p><p>Saint Petersburg</p></bio><email xlink:type="simple">ejvcons@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1793-3240</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Артемова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Artemova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Артемова Анастасия Витальевна, ассистент кафедры неврологии и мануальной медицины Факультета последипломного образования</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Artemova Anastasia V., Assistant of the Department of Neurology and Manual Medicine, Faculty of Postgraduate Education</p><p>Saint Petersburg</p></bio><email xlink:type="simple">katemelnikova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1086-3304</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Семенова Екатерина Валерьевна, клинический ординатор кафедры клинической лабораторной диагностики с курсом молекулярной медицины </p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Semenova V. Ekaterina, Clinical Resident of the Department of Clinical Laboratory Diagnostics with a Course of Molecular Medicine</p><p>Saint Petersburg</p></bio><email xlink:type="simple">katemelnikova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4465-3778</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенова</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenova</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Семенова Варвара Владимировна, клинический ординатор кафедры клинической лабораторной диагностики с курсом молекулярной медицины </p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Semenova V. Varvara, Clinical Resident of the Department of Clinical Laboratory Diagnostics with a Course of Molecular Medicine</p><p>Saint Petersburg</p><p> </p></bio><email xlink:type="simple">varvara1998@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pavlov University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>18</day><month>04</month><year>2022</year></pub-date><volume>29</volume><issue>2</issue><fpage>32</fpage><lpage>40</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Луговая А.В., Эмануэль Ю.В., Артемова А.В., Семенова Е.В., Семенова В.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Луговая А.В., Эмануэль Ю.В., Артемова А.В., Семенова Е.В., Семенова В.В.</copyright-holder><copyright-holder xml:lang="en">Lugovaya A.V., Emanuel Y.V., Artemova A.V., Semenova E.V., Semenova V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sci-notes.ru/jour/article/view/873">https://www.sci-notes.ru/jour/article/view/873</self-uri><abstract><p>Цель – провести сравнительный анализ динамики биомаркеров апоптоза и аутофагии в периферической крови пациентов в остром периоде ишемического инсульта (ИИ) и сопоставить с динамикой тяжести неврологического дефицита по шкале NIHSS (шкала инсульта Национального института здоровья) и объемом очага поражения головного мозга по результатам магнитно-резонансной томографии. Оценить роль изучаемых показателей в прогнозе исхода острого периода заболевания.</p><sec><title>Методы и материалы</title><p>Методы и материалы. Обследованы 56 пациентов в остром периоде впервые развившегося атеротромботического ИИ. Контрольную группу составили 29 здоровых доноров. Пациентам проводили динамическое клинико-неврологическое обследование в 1-е, 7-е и 14-е сутки от начала заболевания. В эти же временные интервалы оценивали динамику экспрессии биомаркеров апоптоза и аутофагии в периферической крови методом проточной цитометрии и сопоставляли с показателями неврологического статуса в 1-е, 7-е и 14-е сутки соответственно с помощью корреляционного анализа.</p></sec><sec><title>Результаты</title><p>Результаты. Статистически достоверное повышение экспрессии аннексина V и каспазы-3, по сравнению с группой контроля, отмечалось на протяжении всего исследования во всех популяциях лейкоцитов с максимальным повышением показателей в первые 24 ч. Повышенные уровни экспрессии аннексина V и каспазы-3 положительно коррелировали с тяжестью неврологического дефицита и объемом повреждения головного мозга в 1-е и 7-е сутки. Выявлена прямая корреляционная зависимость между повышенными значениями биомаркеров аутофагии LC3, CytoID, объемом повреждения головного мозга и тяжестью неврологического дефицита на 7-е сутки.</p></sec><sec><title>Заключение</title><p>Заключение. Статистически значимое повышение биомаркеров апоптоза и аутофагии в периферической крови в остром периоде ИИ коррелирует с тяжестью клинико-неврологических показателей. Роль значительного повышения каспазы-3 как предиктора неблагоприятного исхода заболевания требует дальнейшего изучения.</p></sec></abstract><trans-abstract xml:lang="en"><p>The objective was to conduct a comparative analysis of the dynamics of biomarkers of apoptosis and autophagy in the eripheral blood of patients in the acute period of ischemic stroke (IS) and compare it with the dynamics of the severity of neurological deficit according to the NIHSS (National Institutes of Health Stroke Scale) and the volume of the brain lesion according to the results of magnetic resonance imaging (MRI). To assess the role of the studied parameters in the prognosis of the outcome of the acute period of the disease.</p><sec><title>Methods and material</title><p>Methods and material. We examined 56 patients in the acute period of newly developed atherothrombotic IS. The control group consisted of 29 healthy donors. Patients underwent a dynamic clinical and neurological examination on the 1st, 7th and 14th days from the onset of the disease. At the same time intervals, the dynamics of the expression of biomarkers of apoptosis and autophagy in peripheral blood was evaluated by flow cytometry and compared with neurological status indicators on the 1st, 7th, and 14th  days, respectively, using correlation analysis.</p></sec><sec><title>Results</title><p>Results. A statistically significant increase in the expression of annexin V and caspase-3 compared with the control group was observed throughout the study in all populations of leukocytes with a maximum increase in the first 24 hours. Increased expression levels of annexin V and caspase-3 positively correlated with the severity of neurological deficit and the amount of brain damage on the 1st and 7th days. A direct correlation was found between increased values of autophagy biomarkers LC3, Cyto-ID, the amount of brain damage, and the severity of neurological deficit on the 7th day.</p></sec><sec><title>Conclusion</title><p>Conclusion. A statistically significant increase in biomarkers of apoptosis and autophagy in the peripheral blood in the acute period of IS correlates with the severity of clinical and neurological parameters. The role of a significant increase in caspase-3 as a predictor of adverse disease outcome requires further study.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>апоптоз</kwd><kwd>аутофагия</kwd><kwd>аутофагосома</kwd><kwd>острый ишемический инсульт</kwd><kwd>биомаркеры аутофагии</kwd><kwd>биомаркеры апоптоза</kwd><kwd>LC3</kwd><kwd>р62</kwd><kwd>аннексин V</kwd><kwd>каспаза-3</kwd><kwd>проточная цитометрия</kwd><kwd>клиническая лабораторная диагностика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>apoptosis</kwd><kwd>autophagy</kwd><kwd>acute ischemic stroke</kwd><kwd>autophagy biomarkers</kwd><kwd>apoptosis biomarkers</kwd><kwd>LC3</kwd><kwd>р62</kwd><kwd>annexin V</kwd><kwd>caspase-3</kwd><kwd>flow cytometry</kwd><kwd>clinical laboratory diagnostics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Becker K. Autoimmune Responses to Brain Following Stroke // Translational Stroke research. – 2012. – Vol. 3, № 3. – P. 310–317. Doi: 10.1007/s12975-012-0154-0.</mixed-citation><mixed-citation xml:lang="en">Becker K. Autoimmune Responses to Brain Following Stroke // Translational Stroke research. 2012;3(3):310–317. Doi: 10.1007/s12975-012-0154-0.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lopes-Pinheiro M. A., Kooij G., Mizee M. R. et al. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke // Biochimica et Biophysica Acta. – 2016. – Vol. 1862, № 3. – P. 461–467. Doi: 10.1016/j.bbadis.2015.10.018.</mixed-citation><mixed-citation xml:lang="en">Lopes-Pinheiro M. A., Kooij G., Mizee M. R., Kamermans A., Enzmannb G., Lyck R. et al. Immune cell traffi across the barriers of the central nervous system in multiple sclerosis and stroke // Biochimica et Biophysica Acta. 2016;1862(3):461–467. Doi: 10.1016/j.bbadis.2015.10.018.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Константинова Е. В., Кочетов А. Г., Шостак Н. А. и др. Особенности иммунного ответа и воспалительной реакции при атеротромботическом инсульте и инфаркте миокарда // Журн. неврологии и психиатрии им. С. С. Корсакова. – 2015. – Т. 115, № 12. С. 48–53. Doi: 10.17116/jnevro201511512248-53.</mixed-citation><mixed-citation xml:lang="en">Konstantinova E. V., Kochetov A. G., Shostak N. A., Shurdumova M. Kh., Eremin I. I., Lyang O. V., Skvortsova V. I. Characteristics of immune response and inflammatory reaction in atherothrombotic stroke and myocardial infarction // Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova. 2015;115(12):48–53. (In Russ.). Doi: 10.17116/jnevro201511512248-53.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Клюшник Т. П., Отман И. Н., Чуканова А. С. и др. Динамика маркеров апоптоза в остром периоде ишемического инсульта // Журн. неврологии и психиатрии им. С. С. Корсакова. – 2018. – Т. 118, № 9. – С. 26–31. Doi: 10.17116/jnevro201811809226.</mixed-citation><mixed-citation xml:lang="en">Klushnik. T. P., Otman I. N., Chukanova A. S., Nadareishvili G. G., Guliyieva M. S., Gusev E. I. The dynamics of markers of apoptosis in the acute period of ischemic stroke // Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova. 2018;118(9):26–31. (In Russ.). Doi: 10.17116/jnevro201811809226.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">The critical roles of mitophagy in cerebral ischemia / Y. C. Tang, H. X. Tian, T. Yi, H. B. Chen // Protein Cell. – 2016. – Vol. 7, № 10. – P. 699–713. Doi: 10.1007/s13238-016-0307-0.</mixed-citation><mixed-citation xml:lang="en">Tang Y. C., Tian H. X., Yi T., Chen H. B. The critical roles of mitophagy in cerebral ischemia // Protein Cell. 2016; 7(10):699–713. Doi: 10.1007/s13238-016-0307-0.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gabryel B., Kost A., Kasprowska D. Neuronal autophagy in cerebral ischemia – a potential target for neuroprotective strategies? // Pharmacological Reports. – 2013. – Vol. 64, №1. – P. 1–15. Doi: 10.1016/S1734-1140(12)70725-9.</mixed-citation><mixed-citation xml:lang="en">Gabryel B., Kost A., Kasprowska D. Neuronal autophagy in cerebral ischemia – a potential target for neuroprotective strategies? // Pharmacological Reports. 2013;64(1):1–15. Doi: 10.1016/S1734-1140(12)70725-9.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gong Z., Pan J., Shen Q. et al. Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury // Journal of Neuroinflammation. – 2018. – Vol. 15, № 242. – P. 1–17. Doi: 10.1186/ s12974-018-1282-6.</mixed-citation><mixed-citation xml:lang="en">Gong Z., Pan J., Shen Q., Li M. and Peng Y. Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury // Journal of Neuroinflammation. 2018;15(242):1–17. Doi:10. 1186/s12974018-1282-6.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gao B., Zhang X., Han R. et al. The endoplasmic reticulum stress inhibitor salubrinal inhibits the activation of autophagy and neuroprotection induced by brain ischemic preconditioning // Acta Pharmacologica Sinica. – 2013. – Vol. 34, № 5. – P. 657–666. Doi: 10.1038/aps.2013.34.</mixed-citation><mixed-citation xml:lang="en">Gao B., Zhang X., Han R., Zhang T., Chen C., Qin Z. et al. The endoplasmic reticulum stress inhibitor salubrinal inhibits the activation of autophagy and neuroprotection induced by brain ischemic preconditioning // Acta Pharmacologica Sinica. 2013;34(5):657–666. Doi: 10.1038/aps. 2013.34.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Guan R., Zou W., Dai X. et al. Mitophagy, a potential therapeutic target for stroke // Journal of Biomedical Science. – 2018. – Vol. 25, № 87. – P. 1–16. Doi: 10.1186/s12929-018-0487-4.</mixed-citation><mixed-citation xml:lang="en">Guan R., Zou W., Dai X., Yu X., Liu H., Chen O. et al. Mitophagy, a potential therapeutic target for stroke // Journal of Biomedical Science. 2018;25(87):1–16. Doi: 10.1186/ s12929-018-0487-4.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Revolution in acute ischemic stroke care: a practical guide to mechanical thrombectomy / R. B. Matthew, Р. White, Р. Cowley, D. J. Werring // Рractical neurology. – 2017. – Vol. 17, № 4. – P. 252–265. Doi: 10.1136/practneurol-2017-001685.</mixed-citation><mixed-citation xml:lang="en">Matthew R. B., White P., Cowley P., Werring D. J. Revolution in acute ischemic stroke care: a practical guide to mechanical thrombectomy // Рractical neurology. 2017;17(4):252–265. Doi: 10.1136/practneurol-2017-001685.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Modulating autophagy in mesenchymal stem cells effectively protects against hypoxiaor ischemia-induced injury / С. Hu, L. Zhao, D. Wu, L. Li // Stem Cell Research &amp; Therapy. – 2019. – Vol. 10, № 1. – P. 1–13. Doi: 10.1186/s13287-019-1225-x.</mixed-citation><mixed-citation xml:lang="en">Hu C., Zhao L., Wu D., Li L. Modulating autophagy in mesenchymal stem cells effectively protects against hypoxiaor ischemia-induced injury // Stem Cell Research &amp; Therapy. 2019;10(1):1–13. Doi: 10.1186/s13287-0191225-x.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Клеточная терапия при ишемическом инсульте / В. Н. Александров, Т. А. Камилова, Б. В. Мартынов, Л. И. Калюжная // Вестн. Рос. Военно-мед. акад. – 2013. – Т. 3, № 3. – С. 199–205.</mixed-citation><mixed-citation xml:lang="en">Alexandrov V. N., Kamilova T. A., Martynov B. V., Kalyuzhnaya L. I. Cell therapy in ischemic stroke // Vestnik Rossiyskoy Voyenno-meditsinskoy akademii. 2013; 3(43):199–205. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Jungverdorben J., Till A., Brüstle O. Induced pluripotent stem cell-based modeling of neurodegenerative diseases: a focus on autophagy // Journal of Molecular Medicine. – 2017. – Vol. 95, № 7. – P. 705–718. Doi: 10.1007/s00109017-1533-5.</mixed-citation><mixed-citation xml:lang="en">Jungverdorben J., Till A., Brüstle O. Induced pluripotent stem cell-based modeling of neurodegenerative diseases: a focus on autophagy // Journal of Molecular Medicine. 2017; 95(7):705–718. Doi: 10.1007/s00109-017-1533-5.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Steliga A., Kowiański P., Czuba E. et al. Neurovascular Unit as a Source of Ischemic Stroke Biomarkers—Limitations of Experimental Studies and Perspectives for Clinical Application // Translational Stroke Research. – 2020. – Vol. 11. – P. 553–579. Doi: 10.1007/s12975-019-00744-5.</mixed-citation><mixed-citation xml:lang="en">Steliga A., Kowiański P., Czuba E., Waśkow М., Moryś J., Lietzau G. Neurovascular Unit as a Source of Ischemic Stroke Biomarkers—Limitations of Experimental Studies and Perspectives for Clinical Application // Translational Stroke Research. 2020;(11):553–579. Doi: 10.1007/s12975-01900744-5.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Apoptosis and autophagy, as inherent components of autoimmunity in the acute period of ischemic stroke / A. V. Lugovaya, N. M. Kalinina, E. R. Barancevich, A. V. Artemova // Вестн. Санкт-Петербург. ун-та: Медицина. – 2019. – Т. 14, № 4. – С. 295–298. Doi: 10.21638/spbu11.2019.409.</mixed-citation><mixed-citation xml:lang="en">Lugovaya A. V., Kalinina N. M, Barancevich E. R, Artemova A. V. Apoptosis and autophagy, as inherent components of autoimmunity in the acute period of ischemic stroke // Vestnik Sankt-Peterburgskogo universiteta. Meditsina. 2019;14(4):295–298. (In Russ. ). Doi: 10.21638/spbu11. 2019.409.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W., Meng А. MicroRNA-124 expression in the brains of rats during early cerebral ischemia and reperfusion injury is associated with cell apoptosis involving STAT3 // Experimental and Therapeutic Medicine. – 2019. – Vol. 17, №4. – P. 2870–2876. Doi: 10.3892/etm.2019.7220.</mixed-citation><mixed-citation xml:lang="en">Jin W. N., Gonzales R., Feng Y., Wood K., Chai Z., Dong J. F. et al. Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury // Stroke. 2018;49(6):1471–1478. Doi: 10.1161/STROKEAHA.118.020203.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Jin W. N., Gonzales R., Feng Y. et al. Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury // Stroke. – 2018. – Vol. 49, № 6. – P. 1471–1478. Doi: 10.1161/STROKEAHA.118.020203.</mixed-citation><mixed-citation xml:lang="en">Zhang W., Meng А. MicroRNA-124 expression in the brains of rats during early cerebral ischemia and reperfusion injury is associated with cell apoptosis involving STAT3 // Experimental and Therapeutic Medicine. 2019;17(4):2870– 2876. Doi: 10.3892/etm.2019.7220.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y., Chang C., Chen H. et al. Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy // Arthritis Research &amp; Therapy. – 2018. – Vol. 20, № 268. – P. 1–11. Doi: 10.1186/ s13075-018-1763-0.</mixed-citation><mixed-citation xml:lang="en">Chen Y., Chang C., Chen H., Hsieh C. W., Tang K. T., Yang M. C., Lan J. L., Chen D. Y. Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy // Arthritis Research &amp; Therapy. 2018;20(268):1–11. Doi: 10.1186/s13075-018-1763-0.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Li H., Qiu S., Li X. et al. Autophagy biomarkers in CSF correlates with infarct size, clinical severity and neurological outcome in AIS patients // Journal of Translational Medicine. – 2015. – Vol. 13, № 359. – P. 1–8. Doi: 10.1186/s12967-015-0726-3.</mixed-citation><mixed-citation xml:lang="en">Li H., Qiu S., Li X., Li M., Peng Y. Autophagy biomarkers in CSF correlates with infarct size, clinical severity and neurological outcome in AIS patients // Journal of Translational Medicine. 2015;13(359):1–8. Doi: 10.1186/ s12967-015-0726-3.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Баранова Е. В. Маркеры воспаления у больных с различными типами мозговых инсультов // Международ. невролог. журн. – 2014. – Т. 5, № 67. – С. 45–48.</mixed-citation><mixed-citation xml:lang="en">Baranova Ye. V. Markers of inflammation in patients with different types of cerebral strokes. Mezhdunarodnyy nevrologicheskiy zhurnal. 2014;5(67):45–48. (In Russ ).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Кулеш А. А., Дробаха В. Е., Некрасова И. В. и др. Нейровоспалительные, нейродегенеративные и структурные церебральные маркеры основных клинических вариантов постинсультных когнитивных нарушений в остром периоде ишемического инсульта // Вестн. РАМН. – 2016. – Т. 71, № 4. – С. 304–312.</mixed-citation><mixed-citation xml:lang="en">Kulesh A. A., Drobakha V. E., Nekrasova I. V., Kuklina E. M., Shestakov V. V. Neuroinflammatory, Neurodegenerative and Structural Brain Biomarkers of the Main Types of Post-Stroke Cognitive Impairment in Acute Period of Ischemic Stroke // Vestnik RAMN. 2016;71(4):304–312. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Баринов Э. Ф., Евтушенко С. К., Максименко Т. Л. и др. Механизмы регуляции воспаления в ишемизированном мозге (научный обзор) // Международ. невролог. журн. – 2013. – Т. 8, № 62. – С. 13–21.</mixed-citation><mixed-citation xml:lang="en">Barinov E. F., Yevtushenko S. K., Maksimenko T. L., Barinova M. E., Tverdokhleb T. A., Yevtushenko I. S. Mechanisms of regulation of inflammation in the ischemic brain (scientific review) // Mezhdunarodnyy nevrologicheskiy zhurnal. 2013;8(62):13–21. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tsygan N. V., Trashkov A. P., Litvinenko I. V. et al. Autoimmunity in acute ischemic stroke and the role of bloodbrain barrier: the dark side or the light one? // Frontiers of Medicine. – 2019. – Vol. 13, № 4. – Р. 420–426. Doi: 10.1007/s11684-019-0688-6.</mixed-citation><mixed-citation xml:lang="en">Tsygan N. V., Trashkov A. P., Litvinenko I. V., Yakovleva V. A., Ryabtsev A. V., Andrey G. et al. Autoimmunity in acute ischemic stroke and the role of blood-brain barrier: the dark side or the light one? // Frontiers of Medicine. 2019;13(4):420–426. Doi: 10.1007/s11684-019-0688-6.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
